Discover how the final rule from the CDC expands access to the World Trade Center (WTC) Health Program, now including Pentagon and Shanksville responders. This course unpacks the statutory changes, capped at 500 new enrollees, detailing the impact and compliance with...
FDA’s Final Rule on Nonprescription Drugs with ACNU
$129.99
Discover how the FDA’s final rule on nonprescription drugs with Additional Conditions for Nonprescription Use (ACNU) is transforming the pharmaceutical landscape. This course covers application and labeling requirements, postmarketing reporting, and the dual marketing of prescription and nonprescription drugs, enhancing consumer access to safe medications.
In this course you will learn the following:
* Understand the purpose and scope of the final rule on nonprescription drug products with an ACNU.
* Identify the key requirements for applications, labeling, and postmarketing reporting.
* Recognize the consequences of non-compliance with the final rule.
* Implement actionable steps to ensure compliance with the new regulations.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Additional information
| Federal Register Title | Nonprescription Drug Product With an Additional Condition for Nonprescription Use. Document Number: 2024-30261 |
|---|---|
| Course SKU | FR-24-1116-1 |
| Why This Course Is Important | Without this course, you might struggle to navigate the new FDA requirements for marketing nonprescription drugs with ACNU, potentially risking non-compliance and enforcement actions. |